The revolution of cloud computing is poised to have a major impact on the healthcare technology market. Perhaps nowhere is this more evident than in the developments surrounding medical imaging. While concerns over availability and privacy have slowed adoption to date, those are issues are highly addressable and the market is moving forward. Medical imaging … Continue reading “Medical Images Get Cloudy”
Gaming Not Just for The Hardcore, Boston’s Talent Pool is Hot, and More Takeaways from MIT Sloan’s Business In Gaming Conference
Thursday’s Business in Gaming conference, put on by MIT’s Sloan School of Management, showed me that gamers aren’t afraid to say what they really think. And that Facebook is really stirring debate in the industry, as it is in communication, commerce, advertising, and almost anything else we can think of. I caught a lot of … Continue reading “Gaming Not Just for The Hardcore, Boston’s Talent Pool is Hot, and More Takeaways from MIT Sloan’s Business In Gaming Conference”
Chronix Biomedical Secures $2,781,800 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1e0b1a2f-1745-4a7b-9903-7eded3ff7ed9&Preview=1 Date 3/14/2011 Company Name Chronix Biomedical Mailing Address 5941 Optical Court San Jose, CA 95138 Company Description Chronix Biomedical is pioneering a breakthrough approach to the diagnosis and management of chronic diseases and cancer. It has developed proprietary technology that measures and categorizes circulating nucleic acids, DNA sequences circulating in the … Continue reading “Chronix Biomedical Secures $2,781,800 New Funding”
Living Proof Garners $16,000,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=85a0210e-5fb3-48c1-9c10-727917003ab0&Preview=1 Date 3/14/2011 Company Name Living Proof Mailing Address 63 Rogers St Cambridge, MA 02142 Company Description Living Proof, Inc. provides materials and products for hair care in the United States. It offers straight making no frizz styling sprays, creams, and treatments; and wave shaping curl defining no frizz styling sprays, creams, … Continue reading “Living Proof Garners $16,000,000 Series B Financing”
BoostCTR Secures $1,640,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=88e0c832-6ac5-4ece-ac56-4e39ae173625&Preview=1 Date 3/14/2011 Company Name BoostCTR Mailing Address 548 Market St. San Francisco, CA 94104 Company Description BoostCTR is the first service that lets online marketers crowdsource the optimization and testing of their ad creative on a performance basis. By utilizing our services, marketers not only free up their time, but also … Continue reading “BoostCTR Secures $1,640,000 New Funding Round”
Mozido Secures New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=954e401e-5e36-449f-b1c1-edf7c3443d2a&Preview=1 Date 3/14/2011 Company Name Mozido Mailing Address 1601 South Mopac Expressway Austin, TX 78746 Company Description Across mobile phones, through point-of-sale terminals, over the Internet – Mozido offers the services your customers need, where they need them. Website http://www.mozido.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed Proceeds Purposes … Continue reading “Mozido Secures New Funding”
Xconomy Meetup With Curt Woodward & Luke Timmerman
Come out to meet Xconomy Seattle editor Luke Timmerman and the team’s newest addition, senior editor Curt Woodward, over a beer. We like it if you’ll send an RSVP to [email protected], but we won’t bust your chops if you just stop by unannounced to say Hi.
Dendreon’s Warhorse, Chief Scientific Officer Dave Urdal, To Retire at Year-End
David Urdal, the scientific entrepreneur who co-founded the modern version of Dendreon over 15 years ago and helped turn it into a pioneer of cancer immunotherapy, is stepping down from his job as chief scientific officer at the Seattle biotech company (NASDAQ: [[ticker:DNDN]]). Urdal, 61, will be retiring as Dendreon’s executive vice president and chief … Continue reading “Dendreon’s Warhorse, Chief Scientific Officer Dave Urdal, To Retire at Year-End”
Entretech Forum: Biomedicine: Riding and Surviving the Biotech Funding Roller-Coaster
This panel will bring together experts on investing in biotech to discuss the funding ups and downs of the past few years. Launchpad Venture Group and Mass Medical Angels are among the firms that will be represented, so register online to hear them dish.
University of Michigan Tech Transfer Makes Great Progress in Ten Years. But Is It Enough?
When Ken Nisbet arrived at the University of Michigan in 2001, the Office of Technology Transfer (OTT) was an office in name only. Like at most universities at the time, tech transfer at U-M was an afterthought, a low priority enterprise usually staffed by people with little or no industry experience. But after witnessing the … Continue reading “University of Michigan Tech Transfer Makes Great Progress in Ten Years. But Is It Enough?”
StumbleUpon Stumbles Upon $17M
San Francisco-based StumbleUpon, the Web and mobile service that helps users discover new sites, said this week that it has raised $17 million in Series B venture financing. The round included new investors DAG Ventures and First Round Capital as well as returning investors Accel Partners, August Capital, and Sherpalo Ventures, who financed StumbleUpon’s spinout … Continue reading “StumbleUpon Stumbles Upon $17M”
Babson Awards $75K to SF Entrepreneurs
Babson College this week announced the results of its first “rocket pitch” competition for students entering the Babson Fast Track MBA program at the college’s SoMa campus in San Francisco. Contestants had three minutes and three slides to explain how they meet Babson’s definition of entrepreneurship as “thinking or acting in a manner that is … Continue reading “Babson Awards $75K to SF Entrepreneurs”
BuyWithMe Acquires LocalTwist, Goes Head-to-Head Vs. Tippr While Lawsuits Simmer
This is not just another consolidation of local-deal sites. This is a life-and-death struggle for third place behind Groupon and LivingSocial (for now anyway). This is BuyWithMe vs. Tippr, Round Two. New York- and Boston-based BuyWithMe said today it has acquired LocalTwist, a daily-deals site that is active in Seattle and San Diego, and soon … Continue reading “BuyWithMe Acquires LocalTwist, Goes Head-to-Head Vs. Tippr While Lawsuits Simmer”
VigLink Raises $5.4 Million
VigLink, a San Francisco startup that helps website owners track outgoing traffic—that is, “outclicks” that can drive affiliate commissions—announced yesterday that it has collected $5.4 million in a Series B financing round led by Emergence Capital. Existing backers Google Ventures and First Round Capital also participated. Emergence Capital partner Kevin Spain has joined VigLink’s board. … Continue reading “VigLink Raises $5.4 Million”
Mobile Madness 2011: The Photo Gallery
Thanks again to everyone who joined us for Mobile Madness 2011: Getting Down to Business on Wednesday at Microsoft’s New England Research & Development Center in Cambridge, MA. As I mentioned yesterday in my post-event recap, the capacity crowd was in lean-forward, close-listening mode as leaders of the mobile scene in New England and beyond … Continue reading “Mobile Madness 2011: The Photo Gallery”
RadiumOne Absorbs $21M
Crosslink Capital is the lead investor in a $21 million Series B financing round for RadiumOne, the San Francisco startup announced today. The company uses information about consumers’ social connections online (but outside of Facebook) to aim online advertisements at the users most likely to engage. Also participating in the round was DFJ Esprit, a … Continue reading “RadiumOne Absorbs $21M”
$15M for Intermolecular
San Jose, CA-based Intermolecular, which helps semiconductor and clean-energy companies accelerate R&D through combinatorial chemistry, has raised $15 million out of a potential $25 million in a sale of equity and securities, according to a regulatory filing. The investors in the round were not identified, but Intermolecular’s board includes directors from CMEA Ventures, US Venture … Continue reading “$15M for Intermolecular”
AC/DC Controversy of the 1880s Applies to Natural Gas Today: Reflections After 2011 MIT Energy Conference
In the 1880s, Thomas Edison was locked in a battle with the legendary inventor Nikola Tesla and the entrepreneur George Westinghouse. Edison argued that alternating current was “impractical” and highly dangerous. He supported the demonstration of electrocution of numerous animals to show the press and the public the danger of alternating current. He even went … Continue reading “AC/DC Controversy of the 1880s Applies to Natural Gas Today: Reflections After 2011 MIT Energy Conference”
Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study
There’s some bad news from Cambridge, MA-based Tolerx today. The venture-backed biotech firm and its partner GlaxoSmithKline (NYSE:[[ticker:GSK]]) reported that their experimental drug for Type 1 diabetes failed to meet the main clinical goal of a late-stage study, called Defend-1. The 272-patient Defend-1 study was designed to measure how well newly diagnosed adult patients were … Continue reading “Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study”
Report: Fabry Patients Sue Genzyme and Mt. Sinai Medical School
Six patients with the rare genetic disorder Fabry disease have filed a lawsuit against Cambridge, MA-based biotech company Genzyme (NASDAQ:[[ticker:GENZ]]) and Mt. Sinai Medical School over the handling of a rationing system for Genzyme’s Fabry treatment, agalsidase beta (Fabrazyme), the online publication Pharmalot reported yesterday. Genzyme, which is being bought by the French drug giant … Continue reading “Report: Fabry Patients Sue Genzyme and Mt. Sinai Medical School”
Amazon’s Multi-State Sales Tax Battles are a Sideshow to the Real National Solution, and the Politicians Know It
Revenue-hungry state governments are licking their chops. Stuck with declining tax collections and soaring costs for services, they’re chasing Amazon.com around the country in a series of attempts to make it collect sales taxes. That’s led some to wonder whether this high-tech round of whack-a-mole might be the front edge of a viral political movement … Continue reading “Amazon’s Multi-State Sales Tax Battles are a Sideshow to the Real National Solution, and the Politicians Know It”
Getting Connected with James Fowler: Social Networks in the Real World and in Cyberspace
James Fowler says his work lies at the intersection of the natural and social sciences. As a professor in UC San Diego’s School of Medicine and Division of Social Sciences, his research encompasses social networks, behavioral economics, evolutionary game theory, political participation, and the genetic basis of political behavior. Fowler also is the co-author, with … Continue reading “Getting Connected with James Fowler: Social Networks in the Real World and in Cyberspace”
Exelixis Bags $156M, Tethys Bets on Prevention, UCSF’s Delicate Dance With Industry, & More Bay Area Life Sciences News
One of the highfliers in Bay Area biotech, which had a lousy 2010, looks like it’s turning into a comeback story in 2011. —South San Francisco-based Exelixis (NASDAQ: [[ticker:EXEL]]) scooped up $156 million through a stock offering this week, as investors piled in to get a piece of the action in cabozantinib (XL184). This is … Continue reading “Exelixis Bags $156M, Tethys Bets on Prevention, UCSF’s Delicate Dance With Industry, & More Bay Area Life Sciences News”
Epizyme Nabs Eisai Deal, Termeer Could Make $221.2M From Genzyme Buyout, Gates Funds Nimbus, & More Boston-Area Life Sciences News
We saw some meaty stories on Boston-area drug developers this week, as well as headlines about funding for newer healthcare and health IT startups. —Imprivata of Lexington, MA, is working on carving itself a niche in the crowded space of technology for the secure access of healthcare IT systems, Ryan wrote. The company, which has … Continue reading “Epizyme Nabs Eisai Deal, Termeer Could Make $221.2M From Genzyme Buyout, Gates Funds Nimbus, & More Boston-Area Life Sciences News”
Nimbit Garners $607,642 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=42959497-b713-4489-af76-9776bf45d572&Preview=1 Date 3/11/2011 Company Name Nimbit Mailing Address 47 Mellen St. Framingham, MA 01702 Company Description Our mission is to put musical artists in complete control of their own music business and brand, enabling them to reach their full potential as quickly as possible. Website http://www.nimbit.com Transaction Type Venture Equity Transaction Amount … Continue reading “Nimbit Garners $607,642 New Financing Round”
Nimbit Secures $626,995 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a2799a6b-6f31-46f9-bdb0-d92e1c3f6e53&Preview=1 Date 3/11/2011 Company Name Nimbit Mailing Address 47 Mellen St. Framingham, MA 01702 Company Description Our mission is to put musical artists in complete control of their own music business and brand, enabling them to reach their full potential as quickly as possible. Website http://www.nimbit.com Transaction Type Venture Equity Transaction Amount … Continue reading “Nimbit Secures $626,995 New Round”
Pontiflex Garners $5,999,993 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dc8d541c-4c02-4d76-8a62-d5bbbc7e7cd7&Preview=1 Date 3/11/2011 Company Name Pontiflex Mailing Address 55 Washington Street Brooklyn, NY 11201 Company Description Welcome to Pontiflex, the advertising industry’s only open and transparent lead generation marketplace. In tough economic times, advertisers want to increase their returns on online marketing. So why should they have to pay for clicks and … Continue reading “Pontiflex Garners $5,999,993 New Funding”
Clearwire CEO Morrow Out, Stanton Named Interim Chief
Leadership shake-ups continue at Clearwire: the Kirkland, WA-based company said Thursday that CEO Bill Morrow and two other top officers are out. Board chairman John Stanton, one of Washington state’s wireless pioneers, is now interim chief executive. Clearwire (NASDAQ: [[ticker:CLWR]]) said Morrow is stepping down for personal reasons, and also is leaving as a director … Continue reading “Clearwire CEO Morrow Out, Stanton Named Interim Chief”
WSJ Top 50 Startups List Leaves Much to Be Desired, Especially in Boston (NY Fares Better)
Everyone loves a Top 50 list. Everyone except me. Wall Street Journal, you can take your “Top 50 venture backed companies” list, published today, and…well, just take it. Not just because it counts a grand total of one—ONE—Boston-area company among its luminaries (Westborough, MA-based ExaGrid, at #42). Not just because the criteria for the list … Continue reading “WSJ Top 50 Startups List Leaves Much to Be Desired, Especially in Boston (NY Fares Better)”
Dendreon Gets FDA Green Light for NJ Factory
Seattle-based Dendreon (NASDAQ: [[ticker:DNDN]]) said today it has won FDA clearance to quadruple the output from the New Jersey factory where it makes its lone product, sipuleucel-T (Provenge). The drug, for men with advanced forms of prostate cancer, was first cleared for sale in the U.S. last April, at a time when Dendreon had extremely … Continue reading “Dendreon Gets FDA Green Light for NJ Factory”
Mobile Madness Speakers Dissect 4G, Enterprise Apps, New Interfaces; Zizzout Destealths with Mobile “Visual Marketplace”
If you can measure a conference’s success from the volume level during the closing cocktail hour, then Xconomy’s Mobile Madness forum yesterday in Cambridge, MA, was a smash. A record-setting crowd of more than 250 people headed to the Microsoft New England R&D Center Wednesday afternoon for the third annual edition of Xconomy’s half-day mobile … Continue reading “Mobile Madness Speakers Dissect 4G, Enterprise Apps, New Interfaces; Zizzout Destealths with Mobile “Visual Marketplace””
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News
One of our local billionaires made a couple of significant biotech investments this week, while one of the venerable names from the biotech scene faded away. —The Bill & Melinda Gates Foundation made its first-ever direct equity investment in a for-profit biotech company last week, when it plunked down $10 million on Research Triangle Park, … Continue reading “Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News”
Hello Ambassador Locke, Can You Get Me On the Line With China, Inc.?
Former Washington Gov. Gary Locke’s nomination as the U.S. ambassador to China puts someone the state’s business community knows very well at the forefront of one of the nation’s most important global relationships. That doesn’t mean every Seattle-area company can expect the red-carpet treatment in Beijing—after all, presuming he’s confirmed by the Senate (which seems … Continue reading “Hello Ambassador Locke, Can You Get Me On the Line With China, Inc.?”
Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry
Jeff Bluestone has one of those jobs in academia where you almost expect the guy to wear a flak jacket to work. As executive vice chancellor and provost, part of the gig is to make sure UCSF’s 2,400 very smart, very strong-willed faculty remain happy, and keep doing world-class work in research and teaching. He … Continue reading “Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry”
Concentrix Solar to Build San Diego Plant
San Diego city, utility, and cleantech industry officials are gathering at UC San Diego this morning to announce a 25-year contract that San Diego Gas & Electric has signed with Tenaska Solar Ventures for 150 megawatts from a solar plant to be developed east of San Diego, near El Centro, CA. As part of the … Continue reading “Concentrix Solar to Build San Diego Plant”
SCVNGR Rolls Out Location-Based Deals Service in Boston, Philadelphia
“SCVNGR is kind of a weird company.” That’s what it says in its press release today, so you know it’s true. And not only because it needs to buy a vowel. The Cambridge, MA, location-based gaming startup’s latest “weird” move is a potentially lucrative one. It is entering the local deals sector to compete with … Continue reading “SCVNGR Rolls Out Location-Based Deals Service in Boston, Philadelphia”
Clovr Snaps Up $8.3M
Clovr Media, a Boston-based digital and mobile marketing startup, announced today that it has brought in $8.3 million in a funding round led by Bain Capital Ventures managing director Jeffrey Glass. The round also included Clovr seed investors Kepha Partners and Common Angels, and newly announced angel investor Mark Wright. Clovr, which launched last October, … Continue reading “Clovr Snaps Up $8.3M”
Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai
Cambridge, MA-based Epizyme has nabbed another pharmaceutical partnership. Two months after announcing a deal worth as much as $650 million with GlaxoSmithKline (NYSE:[[ticker:GSK]]), the startup says today that it has landed a partnership with the Japanese drugmaker Eisai to develop drugs against an epigenetic enzyme for treating lymphomas and other cancers. In its latest deal, … Continue reading “Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai”
White Pages’ Hiya Wants to Eat Plaxo’s Lunch by Blending Your Scattered E-Phone Books with Old-School Contact Info
Seattle-based online directory provider WhitePages is unveiling a networked address book application that it says can outperform Plaxo and other startups in the market for wrangling your various digital rolodexes. WhitePages has been testing its Hiya service since last fall, building up knowledge from a base of about 10,000 users. The public beta starts Thursday. … Continue reading “White Pages’ Hiya Wants to Eat Plaxo’s Lunch by Blending Your Scattered E-Phone Books with Old-School Contact Info”
Forma, After Building Cancer Drug Discovery Engine, Makes First Big Bet on Starving Tumors
Forma Therapeutics could choose to do a lot of different things after spending its first couple years raising $50 million, forming a series of partnerships, and assembling a staff of 100 people around the world with all kinds of skills in the cancer drug R&D business. After all that, Cambridge, MA-based Forma has decided to … Continue reading “Forma, After Building Cancer Drug Discovery Engine, Makes First Big Bet on Starving Tumors”
Astute Medical Nabs $13M, Roth Capital Hosts Conference, Kaldor Joins Versant, & More San Diego Life Sciences News
San Diego’s life sciences sector must have been lying low over the past week, as there was scant news from local biotech, diagnostics, and medical device companies. Our roundup is here. —Biopharma executive Stephen Kaldor, who was CEO at San Diego-based Ambrx from 2007 to 2010, has joined Versant Ventures as a venture partner. The … Continue reading “Astute Medical Nabs $13M, Roth Capital Hosts Conference, Kaldor Joins Versant, & More San Diego Life Sciences News”
Bill Gates Backs Nimbus, Betting on Computer-Based Drug Discovery
Here’s a startup that is stepping out of top-secret status in style. Microsoft Chairman Bill Gates, the second-most wealthy person in the world, is one of two new seed investors in the stealthy biotech startup, Nimbus Discovery. Cambridge, MA-based Nimbus, focused on computer-based drug discovery in partnership with the global chemical-simulation software provider Schrödinger, said … Continue reading “Bill Gates Backs Nimbus, Betting on Computer-Based Drug Discovery”
Clovr Media Garners $8,300,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9db9b449-2964-4d7b-af62-6c204bf30d48&Preview=1 Date 3/10/2011 Company Name Clovr Media Mailing Address 225 Franklin St., 26th Floor Boston, MA 02110 Company Description Card Linked Offers (CLOs) are the next generation of digital advertising. A seamless savings experience for consumers, CLOs offer a leap forward for Financial Institutions’ customer loyalty programs and a completely new form … Continue reading “Clovr Media Garners $8,300,000 New Funding”
Nimbus Discovery Garners New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=abe8b11b-af4c-41f0-8e0c-b0a56d36a27e&Preview=1 Date 3/10/2011 Company Name Nimbus Discovery Mailing Address 25 1st St. Cambridge, MA 02141 Company Description Nimbus Discovery is applying advances in computer-based drug discovery to unlock fundamental biological pathways. Nimbus has already delivered selective, potent, and differentiated compounds within the first year for two disease targets, IRAK4 and ACC, which … Continue reading “Nimbus Discovery Garners New Financing Round”
MindSnacks Secures $1,200,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8613e866-4e62-46cf-b590-0b4ab2cd0611&Preview=1 Date 3/10/2011 Company Name MindSnacks Mailing Address Undisclosed San Francisco, CA 94105 Company Description The company makes educational language games for mobile phones. Website http://www.mindsnacks.com Transaction Type Venture Equity Transaction Amount $1,200,000 Transaction Round Undisclosed Proceeds Purposes The firm said that the financing will go toward hiring game designers and engineers. … Continue reading “MindSnacks Secures $1,200,000 New Financing Round”
BAM Labs Receives $2,400,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6284b4ba-ca24-450a-b44f-24270bec013a&Preview=1 Date 3/10/2011 Company Name BAM Labs Mailing Address 170 Knowles Dr. Los Gatos, CA 95032 Company Description The company provides a medical device and service that monitors sleep inpatients. Website http://www.bamlabs.com Transaction Type Venture Equity Transaction Amount $2,400,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. … Continue reading “BAM Labs Receives $2,400,000 New Financing”
Topsy.com Receives $15,000,000 Series C Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed0ff09b-f2cc-495c-8eb0-3b73e2dd3265&Preview=1 Date 3/10/2011 Company Name Topsy.com Mailing Address 140 Second Street FL 6 San Francisco, CA 94105 Company Description Topsy is a new kind of search engine, with a new way of looking at the Internet. Topsy doesn’t think the Internet is a collection of documents. Or even a web of documents. … Continue reading “Topsy.com Receives $15,000,000 Series C Funding”
Intermolecular Lands $14,999,999 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9914cf5d-4c0b-492c-92f6-91baf0b69821&Preview=1 Date 3/10/2011 Company Name Intermolecular Mailing Address 2865 Zanker Road San Jose, CA 95134 Company Description Intermolecular, Inc. delivers High Productivity Combinatorial (HPC) technology products and services that enable customers to maximize semiconductor R&D ROI. The company’s Tempus HPC Platform offers chipmakers, materials suppliers and equipment manufacturers integrated processing, characterization and … Continue reading “Intermolecular Lands $14,999,999 New Financing”
HitPost Receives $500,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=baaa057b-d0b6-4f62-9c57-b9e26d71543d&Preview=1 Date 3/10/2011 Company Name HitPost Mailing Address 301 Brandon St. Fourth Floor San Francisco, CA 94107 Company Description The company operates a sports oriented social network. Website http://www.hitpost.com Transaction Type Venture Equity Transaction Amount $500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. The company’s service is still to … Continue reading “HitPost Receives $500,000 New Funding”
DemandTec Acquires M-Factor for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=78f03d1c-2732-4c2d-9760-0bff78813ff2&Preview=1 Date 3/10/2011 Company Name M-Factor Mailing Address 1400 Fashion Island Boulevard San Mateo, CA 94404 Company Description M-Factor provides marketing investment management solutions that keep analysis up to date and reveal choices with the best bottom-line results. Website http://www.m-factor.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A Terms … Continue reading “DemandTec Acquires M-Factor for Undisclosed Sum”